Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 6.80x is 37% below its estimated 4-year average of 10.74x, near the low end of its estimated 4-year range (4.31x–1699.71x).
As of 2026-10-06T15:01:25.326Z. 27.00% below its estimated 12-month average of 9.31x.
Calculation as of: 2026-10-06T15:01:25.326Z.
Quote observation: 2026-10-06T15:00:36.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b9d80053686f16721d19c62710da14dda18ff2c6e5fba2adc15c1c35f0ac96a2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
6.80x
EV/SALES RATIO AVG TTM
9.31x
EV/SALES RATIO AVG 3Y
9.46x
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-27.00%
CURRENT VS 3Y AVG
-28.12%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.20x
median of 413 covered companies
CURRENT VS SECTOR MEDIAN
+61.90%
vs the sector median at left
Arcutis Biotherapeutics, Inc.
Market Cap
$3.07B
EV/Sales Ratio
6.80x
TTM Avg
9.31x
3Y Avg
9.46x
5Y Avg
N/A
Market Cap
$3.07B
EV/Sales Ratio
N/A
TTM Avg
1.20x
3Y Avg
895.62x
5Y Avg
895.62x
Market Cap
$3.07B
EV/Sales Ratio
802.73x
TTM Avg
1123.66x
3Y Avg
904.58x
5Y Avg
368.85x
Market Cap
$2.81B
EV/Sales Ratio
4.80x
TTM Avg
7.37x
3Y Avg
10.06x
5Y Avg
14.84x
Market Cap
$3.43B
EV/Sales Ratio
2.74x
TTM Avg
3.65x
3Y Avg
3.66x
5Y Avg
4.78x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | $3.07B | 6.80x | 9.31x | 9.46x | N/A |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.07B | N/A | 1.20x | 895.62x | 895.62x |
| Denali Therapeutics Inc. (DNLI)vs › | $3.07B | 802.73x | 1123.66x | 904.58x | 368.85x |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.01B | N/A | N/A | N/A | N/A |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.81B | 4.80x | 7.37x | 10.06x | 14.84x |
| AtriCure, Inc. (ATRC)vs › | $2.78B | 4.71x | 3.13x | 3.31x | 5.18x |
| CareDx, Inc (CDNA)vs › | $3.44B | 6.73x | 3.21x | 2.88x | 3.18x |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.43B | 2.74x | 3.65x | 3.66x | 4.78x |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.70B | 1.51x | 1.36x | 1.94x | 2.46x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 7.54x |
| 2026-10-02 | 7.54x |
| 2026-10-01 | 7.58x |
| 2026-09-30 | 7.91x |
| 2026-09-29 | 8.01x |
| 2026-09-28 | 8.18x |
| 2026-09-25 | 8.06x |
| 2026-09-24 | 7.87x |
| 2026-09-23 | 7.90x |
| 2026-09-22 | 8.31x |
| 2026-09-21 | 7.78x |
| 2026-09-18 | 7.61x |
| 2026-09-17 | 7.92x |
| 2026-09-16 | 7.83x |
| 2026-09-15 | 7.06x |
| 2026-09-14 | 7.28x |
| 2026-09-11 | 7.17x |
| 2026-09-10 | 7.02x |
| 2026-09-09 | 7.16x |
| 2026-09-08 | 7.32x |
| 2026-09-04 | 7.17x |
| 2026-09-03 | 7.10x |
| 2026-09-02 | 7.16x |
| 2026-09-01 | 7.13x |
| 2026-08-31 | 7.19x |
| 2026-08-28 | 7.14x |
| 2026-08-27 | 7.46x |
| 2026-08-26 | 7.54x |
| 2026-08-25 | 7.45x |
| 2026-08-24 | 7.43x |
| 2026-08-21 | 7.52x |
| 2026-08-20 | 7.60x |
| 2026-08-19 | 7.92x |
| 2026-08-18 | 7.95x |
| 2026-08-17 | 7.67x |
| 2026-08-14 | 7.84x |
| 2026-08-13 | 7.74x |
| 2026-08-12 | 7.87x |
| 2026-08-11 | 7.86x |
| 2026-08-10 | 7.76x |
| 2026-08-07 | 7.58x |
| 2026-08-06 | 7.91x |
| 2026-08-05 | 8.63x |
| 2026-08-04 | 8.29x |
| 2026-08-03 | 8.27x |
| 2026-07-31 | 8.55x |
| 2026-07-30 | 8.90x |
| 2026-07-29 | 8.86x |
| 2026-07-28 | 9.04x |
| 2026-07-27 | 8.86x |
| 2026-07-24 | 8.71x |
| 2026-07-23 | 8.70x |
| 2026-07-22 | 8.88x |
| 2026-07-21 | 8.99x |
| 2026-07-20 | 8.76x |
| 2026-07-17 | 9.06x |
| 2026-07-16 | 8.83x |
| 2026-07-15 | 8.84x |
| 2026-07-14 | 8.54x |
| 2026-07-13 | 8.63x |
| 2026-07-10 | 8.83x |
| 2026-07-09 | 9.15x |
| 2026-07-08 | 9.06x |
| 2026-07-07 | 8.80x |
| 2026-07-06 | 8.31x |
| 2026-07-02 | 8.23x |
| 2026-07-01 | 8.24x |
| 2026-06-30 | 8.35x |
| 2026-06-29 | 8.52x |
| 2026-06-26 | 8.60x |
| 2026-06-25 | 8.50x |
| 2026-06-24 | 8.71x |
| 2026-06-23 | 8.37x |
| 2026-06-22 | 8.49x |
| 2026-06-18 | 8.35x |
| 2026-06-17 | 8.35x |
| 2026-06-16 | 8.18x |
| 2026-06-15 | 8.15x |
| 2026-06-12 | 7.78x |
| 2026-06-11 | 7.85x |
| 2026-06-10 | 7.42x |
| 2026-06-09 | 7.29x |
| 2026-06-08 | 6.90x |
| 2026-06-05 | 6.80x |
| 2026-06-04 | 7.02x |
| 2026-06-03 | 6.84x |
| 2026-06-02 | 6.66x |
| 2026-06-01 | 6.87x |
| 2026-05-29 | 6.87x |
| 2026-05-28 | 6.87x |
| 2026-05-27 | 6.78x |
| 2026-05-26 | 6.76x |
| 2026-05-22 | 6.69x |
| 2026-05-21 | 6.73x |
| 2026-05-20 | 6.56x |
| 2026-05-19 | 6.26x |
| 2026-05-18 | 6.43x |
| 2026-05-15 | 6.83x |
| 2026-05-14 | 6.91x |
| 2026-05-13 | 6.94x |
| 2026-05-12 | 6.63x |
| 2026-05-11 | 6.80x |
| 2026-05-08 | 6.78x |
| 2026-05-07 | 6.62x |
| 2026-05-06 | 8.62x |
| 2026-05-05 | 8.35x |
| 2026-05-04 | 8.37x |
| 2026-05-01 | 8.32x |
| 2026-04-30 | 8.28x |
| 2026-04-29 | 7.97x |
| 2026-04-28 | 8.30x |
| 2026-04-27 | 8.35x |
| 2026-04-24 | 8.29x |
| 2026-04-23 | 8.15x |
| 2026-04-22 | 8.47x |
| 2026-04-21 | 8.34x |
| 2026-04-20 | 8.73x |
| 2026-04-17 | 8.75x |
| 2026-04-16 | 8.63x |
| 2026-04-15 | 8.77x |
| 2026-04-14 | 8.95x |
| 2026-04-13 | 8.60x |
| 2026-04-10 | 8.63x |
| 2026-04-09 | 8.76x |
| 2026-04-08 | 8.78x |
| 2026-04-07 | 8.30x |
| 2026-04-06 | 8.44x |
| 2026-04-02 | 8.43x |
| 2026-04-01 | 8.59x |
| 2026-03-31 | 8.40x |
| 2026-03-30 | 7.60x |
| 2026-03-27 | 7.56x |
| 2026-03-26 | 7.97x |
| 2026-03-25 | 8.10x |
| 2026-03-24 | 7.78x |
| 2026-03-23 | 7.94x |
| 2026-03-20 | 7.91x |
| 2026-03-19 | 8.17x |
| 2026-03-18 | 7.92x |
| 2026-03-17 | 8.10x |
| 2026-03-16 | 8.11x |
| 2026-03-13 | 8.11x |
| 2026-03-12 | 8.17x |
| 2026-03-11 | 8.54x |
| 2026-03-10 | 8.77x |
| 2026-03-09 | 8.85x |
| 2026-03-06 | 8.56x |
| 2026-03-05 | 8.55x |
| 2026-03-04 | 8.60x |
| 2026-03-03 | 8.41x |
| 2026-03-02 | 8.83x |
| 2026-02-27 | 9.63x |
| 2026-02-26 | 10.21x |
| 2026-02-25 | 11.50x |
| 2026-02-24 | 11.49x |
| 2026-02-23 | 11.21x |
| 2026-02-20 | 10.83x |
| 2026-02-19 | 11.89x |
| 2026-02-18 | 11.37x |
| 2026-02-17 | 11.33x |
| 2026-02-13 | 11.02x |
| 2026-02-12 | 11.37x |
| 2026-02-11 | 11.32x |
| 2026-02-10 | 11.44x |
| 2026-02-09 | 11.44x |
| 2026-02-06 | 11.63x |
| 2026-02-05 | 11.11x |
| 2026-02-04 | 11.11x |
| 2026-02-03 | 11.16x |
| 2026-02-02 | 10.90x |
| 2026-01-30 | 10.81x |
| 2026-01-29 | 10.96x |
| 2026-01-28 | 10.85x |
| 2026-01-27 | 11.21x |
| 2026-01-26 | 11.21x |
| 2026-01-23 | 11.16x |
| 2026-01-22 | 11.35x |
| 2026-01-21 | 11.37x |
| 2026-01-20 | 11.02x |
| 2026-01-16 | 11.01x |
| 2026-01-15 | 11.23x |
| 2026-01-14 | 11.38x |
| 2026-01-13 | 11.10x |
| 2026-01-12 | 11.40x |
| 2026-01-09 | 12.00x |
| 2026-01-08 | 12.70x |
| 2026-01-07 | 12.57x |
| 2026-01-06 | 12.42x |
| 2026-01-05 | 12.83x |
| 2026-01-02 | 12.33x |
| 2025-12-31 | 12.35x |
| 2025-12-30 | 11.95x |
| 2025-12-29 | 12.15x |
| 2025-12-26 | 12.32x |
| 2025-12-24 | 12.52x |
| 2025-12-23 | 12.46x |
| 2025-12-22 | 12.71x |
| 2025-12-19 | 11.92x |
| 2025-12-18 | 11.82x |
| 2025-12-17 | 12.05x |
| 2025-12-16 | 12.13x |
| 2025-12-15 | 12.31x |
| 2025-12-12 | 12.34x |
| 2025-12-11 | 12.53x |
| 2025-12-10 | 12.65x |
| 2025-12-09 | 12.65x |
| 2025-12-08 | 13.18x |
| 2025-12-05 | 13.25x |
| 2025-12-04 | 13.23x |
| 2025-12-03 | 12.73x |
| 2025-12-02 | 12.51x |
| 2025-12-01 | 12.90x |
| 2025-11-28 | 13.02x |
| 2025-11-26 | 13.15x |
| 2025-11-25 | 13.05x |
| 2025-11-24 | 13.07x |
| 2025-11-21 | 12.54x |
| 2025-11-20 | 11.63x |
| 2025-11-19 | 11.87x |
| 2025-11-18 | 11.61x |
| 2025-11-17 | 11.15x |
| 2025-11-14 | 10.66x |
| 2025-11-13 | 9.76x |
| 2025-11-12 | 10.01x |
| 2025-11-11 | 10.25x |
| 2025-11-10 | 10.14x |
| 2025-11-07 | 10.34x |
| 2025-11-06 | 10.70x |
| 2025-11-05 | 10.40x |
| 2025-11-04 | 10.25x |
| 2025-11-03 | 10.56x |
| 2025-10-31 | 10.79x |
| 2025-10-30 | 10.63x |
| 2025-10-29 | 10.78x |
| 2025-10-28 | 12.17x |
| 2025-10-27 | 9.61x |
| 2025-10-24 | 9.83x |
| 2025-10-23 | 9.82x |
| 2025-10-22 | 9.69x |
| 2025-10-21 | 10.09x |
| 2025-10-20 | 10.21x |
| 2025-10-17 | 10.21x |
| 2025-10-16 | 10.22x |
| 2025-10-15 | 10.57x |
| 2025-10-14 | 9.99x |
| 2025-10-13 | 10.13x |
| 2025-10-10 | 9.81x |
| 2025-10-09 | 10.12x |
| 2025-10-08 | 10.38x |
| 2025-10-07 | 10.06x |
| 2025-10-06 | 9.67x |
| 2025-10-03 | 9.74x |
| 2025-10-02 | 10.38x |
| 2025-10-01 | 9.67x |
| 2025-09-30 | 9.23x |
| 2025-09-29 | 9.12x |
| 2025-09-26 | 8.61x |
| 2025-09-25 | 8.21x |
| 2025-09-24 | 8.48x |
| 2025-09-23 | 8.62x |
Showing the most recent 260 of 978 data points. The chart above shows the full history.
